Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Analytical Biochemistry|January 15, 2008
A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71Jin-Ching Lee, Shin-Ru Shih, Ten-Yuan Chang, et al.
Journal of the Chinese Medical Association : JCMA|April 5, 2019
Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis CBatbold Batsaikhan, Ming-Ying Lu, Ming-Lun Yeh, et al.
Frontiers in Microbiology|November 21, 2022
Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probeChih-Hung Chuang, Tian-Lu Cheng, Wei-Chun Chen, et al.
Plos One|May 13, 2022
Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patientsBatbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, et al.
European Journal of Medicinal Chemistry|December 9, 2014
New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2Dinesh Manvar, Sveva Pelliccia, Giuseppe La Regina, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Novel Aporphine- and Proaporphine-Clerodane Hybrids Identified from the Barks of Taiwanese Polyalthia longifolia (Sonn.) Thwaites var. pendula with Strong Anti-DENV2 ActivityI-Wen Lo, Geng-You Liao, Jin-Ching Lee, et al.
Cell Death & Disease|June 15, 2018
Mitochondrial Lon sequesters and stabilizes p53 in the matrix to restrain apoptosis under oxidative stress via its chaperone activityYa-Ju Sung, Ting-Yu Kao, Cheng-Liang Kuo, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2024
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivirWen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2025
Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studiesWen-Fang Tang, Hui-Ping Tsai, Yuan-Fan Chin, et al.
Pageof 9